Acceptability of and satisfaction with continuous glucose monitoring in pregnant women with type 2 diabetes mellitus: a service improvement project
File(s)Acceptability Libre_JH2AugSB17augFR20Aug[1].docx (219.25 KB)
Accepted version
Author(s)
Type
Journal Article
Abstract
Background
There are limited data regarding intermittently scanned continuous glucose monitoring (isCGM) in pregnancy for women with Type 2 diabetes. We have tested the acceptability and feasibility of an isCGM method using Libre device.
Method
In a hospital-based service improvement project, 23 pregnant women (March 2022-April 2023), with Type 2 diabetes got isCGM for monitoring from 20 weeks until delivery. Women completed a structured and validated questionnaire assessing satisfaction, equipment issue, relationship with diabetes team.
Results
Two-thirds of the women were satisfied with the convenience and found it reliable. 86% wanted to use it for future pregnancies, and 90% would recommend it to others. Sensor falls off was seen in three obese women and about a tenth felt the reliability was poor in extreme ranges of sugar levels. The relationship with the diabetes team was rated high.
Conclusion
isCGM could be a useful and well-received tool for improving glycaemic control in pregnancies with Type 2 diabetes.
There are limited data regarding intermittently scanned continuous glucose monitoring (isCGM) in pregnancy for women with Type 2 diabetes. We have tested the acceptability and feasibility of an isCGM method using Libre device.
Method
In a hospital-based service improvement project, 23 pregnant women (March 2022-April 2023), with Type 2 diabetes got isCGM for monitoring from 20 weeks until delivery. Women completed a structured and validated questionnaire assessing satisfaction, equipment issue, relationship with diabetes team.
Results
Two-thirds of the women were satisfied with the convenience and found it reliable. 86% wanted to use it for future pregnancies, and 90% would recommend it to others. Sensor falls off was seen in three obese women and about a tenth felt the reliability was poor in extreme ranges of sugar levels. The relationship with the diabetes team was rated high.
Conclusion
isCGM could be a useful and well-received tool for improving glycaemic control in pregnancies with Type 2 diabetes.
Date Issued
2025-03-01
Date Acceptance
2024-03-01
Citation
Obstetric Medicine, 2025, 18 (1), pp.12-17
ISSN
1753-4968
Publisher
SAGE Publications
Start Page
12
End Page
17
Journal / Book Title
Obstetric Medicine
Volume
18
Issue
1
Copyright Statement
Copyright © The Author(s) 2024. This is the author’s accepted manuscript made available under a CC-BY licence in accordance with Imperial’s Research Publications Open Access policy (www.imperial.ac.uk/oa-policy)
License URL
Identifier
https://journals.sagepub.com/doi/10.1177/1753495X241233030
Subjects
continuous glucose monitoring
Libre 2 flash monitoring
Life Sciences & Biomedicine
Obstetrics & Gynecology
Pregnancy in diabetics
real-life acceptability
Science & Technology
type 2 diabetes
Publication Status
Published
Date Publish Online
2024-03-06